NCT00158548View on ClinicalTrials.gov

ACT With Chloroquine, Amodiaquine & Sulphadoxine-pyrimethamine in Pakistan

PHASE3CompletedINTERVENTIONAL
Enrollment

650

Participants

Timeline

Start Date

June 30, 2001

Study Completion Date

December 31, 2004

Conditions
MalariaFalciparum MalariaVivax Malaria
Interventions
DRUG

SP, chloroquine, amodiaquine, primaquine, artesunate

Trial Locations (1)

Unknown

HealthNet International, Peshawar

Sponsors

Collaborators (1)

HealthNet TPO
All Listed Sponsors
collaborator

World Health Organization

OTHER

collaborator

HealthNet TPO

OTHER

collaborator

United Nations High Commissioner for Refugees

OTHER

collaborator

Malaria Control Program, Directorate of Malaria Control, Pakistan

OTHER

lead

London School of Hygiene and Tropical Medicine

OTHER